Patent Assignment
Reel/Frame 059049/0164
SECURITY INTEREST
Recorded: 2022-02-18
Received: 2022-02-18
Pages: 7
Assignor
AMRYT PHARMACEUTICALS, INC.
Executed: 2022-02-18
Assignee
ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
245 PARK AVENUE, 44TH FLOOR, NEW YORK, NY, 10167, UNITED STATES
Covered Applications
(6)
METHODS OF DETECTING ANTI-LEPTIN NEUTRALIZING ANTIBODIES
App. No. 16/996,281
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
App. No. 16/751,538
→
COMPOUND IMPURITIES AND METHODS OF DETECTING SAME
App. No. 15/570,246
→
Methods of Detecting Anti-Leptin Neutralizing Antibodies
App. No. 15/702,719
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
App. No. 14/837,705
→
A CHIMERIC LEPTIN POLYPEPTIDE AND METHOD OF USING THE SAME
App. No. 14/703,523
→